research Is Lichen Planus a Marker for Dyslipidemia and Metabolic Syndrome?
Lichen planus may be associated with a higher risk of metabolic syndrome.
Search
for
Sort by
Research
900-930 / 1000+ results 
research Association of Insulin-Like Growth Factor 2 Apa1 A820G Gene (rs680) Polymorphism with Polycystic Ovarian Syndrome
A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.
research Dermabrasion and Microdermabrasion: Rationale, Application, Safety Concerns, and Complications
Understanding and careful application of dermabrasion and microdermabrasion can minimize risks and improve patient outcomes.
research Polycystic Ovary Syndrome: Symptoms, Risks, and Treatments
PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.
research Treatment of Actinic Cheilitis with Ingenol Mebutate Gel: Experience in Four Patients
Finasteride for hair loss in young men increases the risk of sexual dysfunction.
research Study of QuantiFERON’s Conversion/Reversal Phenomena in Patients with Psoriasis During Biological Treatment
Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.
research Sex Hormones and Related Compounds, Including Hormonal Contraceptives
Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.
research A Synonymous Polymorphism of APCDD1 Affects Translation Efficacy and Is Associated with Androgenic Alopecia
A specific gene change in APCDD1 increases the risk of hair loss.
research Male Pattern Baldness Linked to Prostate Problems
Men with pattern baldness may have a higher risk of prostate issues.
research BJD Editor's Choice: Genetic Mutations in Greek Melanoma Patients, Dermoscopic Features of Pigmented Nodular Tumors, Herlitz Junctional Epidermolysis Bullosa in the Netherlands, and HDAC9 in Male-Pattern Baldness
Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.
research Urological Oncology: Prostate Cancer
Male pattern baldness may be linked to prostate cancer risk.
research Adverse Effects and Drug Interactions of Biologic Agents
Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.
research Association of Psoriasis and Psoriatic Arthritis with Human Leukocyte Antigen and Killer Cell Immunoglobulin-Like Receptor Gene Frequency: A Multiethnic Population Study
Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.
research Prostate Specific Antigen Levels in Diabetic and Non-Diabetic Men from the 2001–2002 National Health and Nutrition Examination Survey
Long-term diabetes is linked to lower prostate cancer risk.
research A National Ethics Committee: Findings on Health Issues and Recommendations
Taking calcium may help elderly with osteoporosis, birth control with levonorgestrel doesn't increase heart attack risk, Salmonella can cause arthritis, a national ethics committee is recommended, and sulfasalazine might help with a hair loss condition.
research Relationship Between Plasma Sex Hormones and Severity of Coronary Artery Disease
Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.
research A Study to Assess the Relationship Between Female Pattern Hair Loss and Levels of Serum 25 Hydroxyvitamin D and Ferritin
Low levels of vitamin D and ferritin may increase the risk of female pattern hair loss.
research Second-To-Fourth Digit Ratio and Age Predicting the Severity of Androgenetic Alopecia: A Cross-Sectional Study
Lower 2D:4D ratio and older age increase the risk of severe hair loss in men.
research Early Onset Androgenic Alopecia in Males, a Marker for Metabolic Syndrome? A Case Control Study
Early hair loss in young men is linked to higher risk of metabolic syndrome.
research The Prevalence of Metabolic Syndrome in Male Patients of Early Onset Androgenic Alopecia Compared to Age-Matched Controls
Men with early-onset hair loss have a higher risk of metabolic syndrome.
research Carotid Intima-Media Thickness in Androgenic Alopecia Patients
Women with androgenic alopecia may have a higher risk of artery problems.
research Lipid Profile in Androgenetic Alopecia
People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.
research Prostate Cancer and Androgenic Alopecia: The Role of Finasteride as a Dual Agent
Finasteride treats hair loss and reduces prostate cancer risk.
research Association of Early-Onset Androgenetic Alopecia with Metabolic Syndrome: A Case-Control Study on 46 Patients in a Tertiary Care Hospital in South India
Early-onset hair loss may be linked to higher risk of metabolic syndrome.
research RF-Scalp Cooling: Reducing Chemotherapy-Induced Hair Loss
Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.
research The Relation Between the Severity of Androgenetic Alopecia and Cardiovascular Atherosclerosis Measured via Carotid Intima-Media Thickness and the SYNTAX Score
Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).
research Correlation of Androgenetic Alopecia and Early Onset Coronary Heart Disease in Men
Men with early-onset baldness may have a higher risk of heart disease.
research Correlation of Carotid Intima Media Thickness and Aortic Stiffness Index with Androgenetic Alopecia
Men with severe hair loss may have a higher risk of heart disease.
research Faculty Opinions Recommendation of Association of Androgenetic Alopecia with Mortality from Diabetes Mellitus and Heart Disease
People with moderate or severe hair loss are at a higher risk of dying from diabetes and heart disease.
research The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.